The global medical robotic systems market was worth $5.48 billion in 2011 and is expected to reach $13.6 billion in 2018, growing at a compounded annual growth rate of 12.6% from 2012 .
XACT’s technology can apply to a wide range of applications, procedures and target organs using different imaging systems within the image guided and robot-assisted surgery market. After careful consideration the Company decided to initially address the growing need for novel technology to assist in CT guided procedures.
Biopsies, ablations and other interventional procedures are currently performed manually under CT guidance by interventional radiologists.
The market is in need of a safe, accurate, and predictable method for performing interventional CT-guided procedures, which will allow more interventional radiologists to safely and effectively treat more patients in need.